[go: up one dir, main page]

PT3248967T - Forma cristalina de um derivado de benzimidazol e um método de preparação da mesma - Google Patents

Forma cristalina de um derivado de benzimidazol e um método de preparação da mesma

Info

Publication number
PT3248967T
PT3248967T PT158790683T PT15879068T PT3248967T PT 3248967 T PT3248967 T PT 3248967T PT 158790683 T PT158790683 T PT 158790683T PT 15879068 T PT15879068 T PT 15879068T PT 3248967 T PT3248967 T PT 3248967T
Authority
PT
Portugal
Prior art keywords
preparation
crystalline form
novel crystalline
benzimidazole derivative
benzimidazole
Prior art date
Application number
PT158790683T
Other languages
English (en)
Original Assignee
Hk Inno N Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56417901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3248967(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hk Inno N Corp filed Critical Hk Inno N Corp
Publication of PT3248967T publication Critical patent/PT3248967T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT158790683T 2015-01-20 2015-11-18 Forma cristalina de um derivado de benzimidazol e um método de preparação da mesma PT3248967T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150009326A KR101684053B1 (ko) 2015-01-20 2015-01-20 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법

Publications (1)

Publication Number Publication Date
PT3248967T true PT3248967T (pt) 2020-09-11

Family

ID=56417901

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158790683T PT3248967T (pt) 2015-01-20 2015-11-18 Forma cristalina de um derivado de benzimidazol e um método de preparação da mesma

Country Status (33)

Country Link
US (1) US9908870B2 (pt)
EP (1) EP3248967B1 (pt)
JP (2) JP6535748B2 (pt)
KR (1) KR101684053B1 (pt)
CN (2) CN107207478B (pt)
AR (1) AR103444A1 (pt)
BR (1) BR102016001167B1 (pt)
CL (1) CL2017001377A1 (pt)
CO (1) CO2017005396A2 (pt)
CY (1) CY1123423T1 (pt)
DK (1) DK3248967T3 (pt)
EA (1) EA030919B1 (pt)
EC (1) ECSP17035416A (pt)
ES (1) ES2816646T3 (pt)
GE (1) GEP20196974B (pt)
HR (1) HRP20201275T1 (pt)
HU (1) HUE050979T2 (pt)
IL (1) IL253186B (pt)
JO (1) JO3592B1 (pt)
LT (1) LT3248967T (pt)
MX (1) MX359916B (pt)
MY (1) MY186830A (pt)
PH (2) PH12016000029B1 (pt)
PL (1) PL3248967T3 (pt)
PT (1) PT3248967T (pt)
RS (1) RS60758B1 (pt)
SA (1) SA517381904B1 (pt)
SG (1) SG10201509488YA (pt)
SI (1) SI3248967T1 (pt)
SM (1) SMT202000688T1 (pt)
TW (1) TWI589575B (pt)
UY (1) UY36521A (pt)
WO (1) WO2016117814A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101829706B1 (ko) * 2016-09-21 2018-02-19 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 산부가염
KR20230114163A (ko) 2022-01-24 2023-08-01 엠에프씨 주식회사 칼륨 경쟁적 위산분비억제제 계열 약물의 신규한 무정형 고체분산체 및 그의 제조방법
KR20230114164A (ko) 2022-01-24 2023-08-01 엠에프씨 주식회사 벤즈이미다졸 유도체의 공동 무정형 고형체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
KR20240028127A (ko) 2022-08-24 2024-03-05 위더스제약주식회사 테고프라잔 고체분산체 조성물
WO2024045255A1 (zh) * 2022-08-30 2024-03-07 上海皓元医药股份有限公司 一种特戈拉赞晶型b及其制备方法
KR20240109898A (ko) 2023-01-05 2024-07-12 위더스제약주식회사 무정형 테고프라잔 고체분산체
KR20240120271A (ko) 2023-01-31 2024-08-07 주식회사 엔비피헬스케어 신규한 테고프라잔 말론산 공무정형
KR20250149709A (ko) * 2023-02-18 2025-10-16 리 파르마 리미티드 포타슘-경쟁적 위산분비 차단제의 안정한 비정질 형태 및 이의 제조 방법
KR20240131641A (ko) 2023-02-24 2024-09-02 엠에프씨 주식회사 신규 테고프라잔의 염 결정형 및 이의 용매화물 결정형, 및 이들의 제조방법
KR102715562B1 (ko) 2023-03-16 2024-10-11 (주) 에프엔지리서치 테고프라잔의 신규 염 및 이의 제조 방법
CN116178352A (zh) * 2023-03-16 2023-05-30 宙晟智维生命科学(上海)有限公司 一种氮稠杂环化合物的晶型及其制备方法
KR20240160980A (ko) 2023-05-03 2024-11-12 구주제약주식회사 신규한 테고프라잔 공무정형
CN116621821A (zh) * 2023-05-29 2023-08-22 宙晟智维生命科学(上海)有限公司 一种无定形的苯并咪唑基化合物及固体分散体
KR20240171624A (ko) 2023-05-31 2024-12-09 권대길 치환된 벤즈이미다졸의 결정형 및 이의 제조방법
KR20240171566A (ko) 2023-05-31 2024-12-09 주식회사 셀트리온제약 테고프라잔의 신규한 공동무정형 및 이를 포함하는 약학 조성물
KR20240174813A (ko) * 2023-06-09 2024-12-17 이니스트에스티 주식회사 크로메인 치환 벤즈이미다졸 유도체 및 염화아연을포함하는 공결정 고체 및 그 제조방법
CN116715660A (zh) * 2023-06-14 2023-09-08 上海柏狮生物科技有限公司 一种特格拉赞的无定型物及其制备方法
KR102866076B1 (ko) * 2023-07-05 2025-09-29 주식회사 다산제약 고순도의 무정형 테고프라잔 제조방법
KR20250041270A (ko) 2023-09-18 2025-03-25 (주)국전약품 벤즈이미다졸 유도체의 공결정화물, 및 이를 포함하는 약제학적 조성물
KR20250066641A (ko) 2023-11-07 2025-05-14 엠에프씨 주식회사 테고프라잔 말리에이트염 1수화물 결정형 및 이의 제조방법
KR20250088407A (ko) * 2023-12-08 2025-06-17 주식회사 종근당 테고프라잔 설폰산염의 신규 결정형 및 이를 포함하는 약제학적 조성물
KR20250118583A (ko) 2024-01-30 2025-08-06 진양제약주식회사 테고프라잔을 포함하는 제약 조성물
KR20250140387A (ko) 2024-03-18 2025-09-25 최광진 벤즈이미다졸 유도체 약물의 신규한 공결정 소재 및 그의 제조방법
WO2025232904A1 (zh) * 2024-05-10 2025-11-13 上海新礼泰药业有限公司 替戈拉生富马酸单乙酯、其制备方法、药物组合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043063A1 (es) * 2002-12-13 2005-07-13 Altana Pharma Ag Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
US7256294B2 (en) * 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
ATE442140T1 (de) * 2005-06-14 2009-09-15 Raqualia Pharma Inc Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten
EP1963311B1 (en) * 2005-12-19 2010-06-16 RaQualia Pharma Inc Chromane substituted benzimidazoles and their use as acid pump inhibitors
EP2650296A1 (en) * 2008-07-03 2013-10-16 Ratiopharm GmbH Crystalline salts of sitagliptin
CN102470126A (zh) * 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
JP2014047304A (ja) * 2012-08-31 2014-03-17 Sanyo Chem Ind Ltd 樹脂粒子の製造方法
GB2508352B (en) * 2012-11-28 2017-08-16 Douwe Egberts Bv Treating soluble coffee
BR112015016370A2 (pt) * 2013-01-11 2017-07-11 Novartis Ag formas de sais de meglumina de ácido 2-((1r,4r)-4-(-4-(5-(benzoxazol-2-ilamino)piridinila-2-il)fenil)ciclo-hexila) acético e seus usos como inibidores de dgat1
PH12017500993B1 (en) * 2014-12-19 2022-06-17 Glaxosmithkline Ip Dev Ltd 3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors

Also Published As

Publication number Publication date
MX2016000751A (es) 2016-08-11
IL253186A (en) 2018-04-30
SG10201509488YA (en) 2016-08-30
CN111187259B (zh) 2023-10-13
EA030919B1 (ru) 2018-10-31
WO2016117814A2 (ko) 2016-07-28
CY1123423T1 (el) 2021-12-31
UY36521A (es) 2016-08-31
KR101684053B1 (ko) 2016-12-08
US9908870B2 (en) 2018-03-06
SI3248967T1 (sl) 2020-11-30
WO2016117814A3 (ko) 2016-10-06
JO3592B1 (ar) 2020-07-05
BR102016001167A2 (pt) 2018-03-20
MY186830A (en) 2021-08-24
PH12016000029A1 (en) 2017-07-24
EA201791151A1 (ru) 2017-12-29
LT3248967T (lt) 2020-10-12
CL2017001377A1 (es) 2017-12-15
CN111187259A (zh) 2020-05-22
JP2019104760A (ja) 2019-06-27
GEP20196974B (en) 2019-06-10
US20180009791A1 (en) 2018-01-11
AR103444A1 (es) 2017-05-10
SA517381904B1 (ar) 2020-12-07
SMT202000688T1 (it) 2021-01-05
TW201627305A (zh) 2016-08-01
EP3248967A4 (en) 2018-10-03
RS60758B1 (sr) 2020-10-30
CN107207478A (zh) 2017-09-26
HUE050979T2 (hu) 2021-01-28
JP6535748B2 (ja) 2019-06-26
MX359916B (es) 2018-10-15
EP3248967A2 (en) 2017-11-29
PH12019000462A1 (en) 2020-10-12
CN107207478B (zh) 2020-09-01
JP2018502140A (ja) 2018-01-25
HRP20201275T1 (hr) 2020-11-13
PL3248967T3 (pl) 2020-12-28
KR20160089928A (ko) 2016-07-29
DK3248967T3 (da) 2020-09-07
ECSP17035416A (es) 2017-11-30
BR102016001167B1 (pt) 2023-03-07
ES2816646T3 (es) 2021-04-05
PH12016000029B1 (en) 2017-07-24
CO2017005396A2 (es) 2017-07-11
IL253186B (en) 2020-11-30
EP3248967B1 (en) 2020-06-24
TWI589575B (zh) 2017-07-01

Similar Documents

Publication Publication Date Title
IL253186B (en) A new crystalline form of a benzaimidazole derivative and a method for its preparation
ZA201901976B (en) Method of reducing crop damage
ZA201800637B (en) Methyl acetate preparation method
IL255738A (en) A new crystalline form of lenbatinib mesylate and a process for its preparation
SI3216790T1 (sl) Kristalinična oblika bisulfata inhibitorja JAK-kinaze in postopek priprave le-te
IL254530A0 (en) Preparation method of crystalline form a of pci-32765
SG11201911164WA (en) Method for preparing intermediate of 4-methoxypyrrole derivative
GB201522771D0 (en) Crystalline form of a phosphate derivative
PL3327012T3 (pl) Krystaliczne postacie bilastyny i sposoby ich wytwarzania
IL258520B (en) A method for the preparation of 2-mercaptobenzothiazole
IL272811A (en) Thiazole derivative production method
IL254597A0 (en) Crystalline form of ahu377, method for its preparation and use
LT3348546T (lt) Androgeno receptorių inhibitoriaus kristalinė forma ir jos gavimo būdas
PT3506747T (pt) Método de redução de danos em culturas
GB201515305D0 (en) Method of preventing a fall
GB201500507D0 (en) Method of manufacturing structural member